These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12499598)

  • 1. Effect of the hydrophobic nature of triacetyl-beta-cyclodextrin on the complexation with nicardipine hydrochloride: physicochemical and dissolution properties of the kneaded and spray-dried complexes.
    Fernandes CM; Veiga FJ
    Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1597-602. PubMed ID: 12499598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds.
    Fernandes CM; Teresa Vieira M; Veiga FJ
    Eur J Pharm Sci; 2002 Feb; 15(1):79-88. PubMed ID: 11803134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.
    Corti G; Capasso G; Maestrelli F; Cirri M; Mura P
    J Pharm Biomed Anal; 2007 Nov; 45(3):480-6. PubMed ID: 17822867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
    Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Nanoencapsulation of Sepiapterin within PEG-PCL Nanoparticles by Complexation with Triacetyl-Beta Cyclodextrin.
    Kuplennik N; Sosnik A
    Molecules; 2019 Jul; 24(15):. PubMed ID: 31357400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.
    Fernandes CM; Ramos P; Falcão AC; Veiga FJ
    J Control Release; 2003 Feb; 88(1):127-34. PubMed ID: 12586510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L; Garnero C; Chattah AK; Delvadia P; Karnes T; Longhi MR; Salgado HR
    AAPS PharmSciTech; 2015 Jun; 16(3):683-91. PubMed ID: 25511811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.
    Patel HM; Suhagia BN; Shah SA; Rathod IS; Parmar VK
    Acta Pharm; 2007 Sep; 57(3):351-9. PubMed ID: 17878114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preformulative assessment of preformed complexes of gemfibrozil, with cyclodextrins.
    Ain S; Philip B; Pathak K
    PDA J Pharm Sci Technol; 2008; 62(4):300-8. PubMed ID: 19174958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of pioglitazone cyclodextrin inclusion complexes.
    Pandit V; Gorantla R; Devi K; Pai R; Sarasija S
    J Young Pharm; 2011 Oct; 3(4):267-74. PubMed ID: 22224032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in solubility and dissolution rate of 1, 2-dithiole-3-thiones upon complexation with beta-cyclodextrin and its hydroxypropyl and sulfobutyl ether-7 derivatives.
    Dollo G; Le Corre P; Chollet M; Chevanne F; Bertault M; Burgot JL; Le Verge R
    J Pharm Sci; 1999 Sep; 88(9):889-95. PubMed ID: 10479350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
    Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
    Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
    Giri BR; Lee J; Lim DY; Kim DW
    Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes.
    Rudrangi SR; Bhomia R; Trivedi V; Vine GJ; Mitchell JC; Alexander BD; Wicks SR
    Int J Pharm; 2015 Feb; 479(2):381-90. PubMed ID: 25579867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M; Panchpuri M; Singh D; Semalty A
    Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M; Maestrelli F; Bragagni M; Mura P
    J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
    Bhargava S; Agrawal GP
    Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced pharmacological efficacy of sumatriptan due to modification of its physicochemical properties by inclusion in selected cyclodextrins.
    Paczkowska M; Mizera M; Sałat K; Furgała A; Popik P; Knapik-Kowalczuk J; Krause A; Szymanowska-Powałowska D; Fojud Z; Kozak M; Paluch M; Cielecka-Piontek J
    Sci Rep; 2018 Nov; 8(1):16184. PubMed ID: 30385844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M; Rangoni C; Maestrelli F; Corti G; Mura P
    Drug Dev Ind Pharm; 2005 Aug; 31(7):697-707. PubMed ID: 16207617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.